| Followers | 51 |
| Posts | 13666 |
| Boards Moderated | 0 |
| Alias Born | 06/15/2014 |
Thursday, October 24, 2024 7:54:56 PM
Recent ARDX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/25/2025 09:38:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/25/2025 09:22:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/24/2025 11:03:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/20/2025 10:46:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/20/2025 10:23:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/20/2025 10:06:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/20/2025 09:51:42 PM
- Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week • GlobeNewswire Inc. • 11/07/2025 09:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2025 09:04:50 PM
- Ardelyx to Participate at the Jefferies Global Healthcare Conference in London • GlobeNewswire Inc. • 11/05/2025 01:00:00 PM
- Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference • GlobeNewswire Inc. • 11/04/2025 01:00:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 11/03/2025 09:48:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/03/2025 09:46:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2025 08:16:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:09:10 PM
- Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 10/30/2025 08:01:00 PM
- Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting • GlobeNewswire Inc. • 10/28/2025 12:01:00 PM
- Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week • GlobeNewswire Inc. • 10/21/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 12:27:52 PM
- Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025 • GlobeNewswire Inc. • 10/13/2025 12:35:00 PM
- Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer • GlobeNewswire Inc. • 10/13/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2025 11:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2025 11:29:52 PM
Alliance Creative Group (ACGX) Announces the Launch of the Alliance Creative Ai Agency and ACGX.AI • ACGX • Dec 15, 2025 8:30 AM
One World Products (to become Isiah Enterprises) Targets December Operational Breakeven; 250,000+ Pounds of Pelletized Rubber Shipped • OWPC • Dec 10, 2025 11:24 AM
Growing Momentum Signals Opportunity as Explorers Shift Toward Production, Reveal Substantial Value • LFLRF • Dec 10, 2025 9:00 AM
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • BLEG • Dec 10, 2025 9:00 AM
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing • BLO • Dec 9, 2025 8:45 AM
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival • AVAI • Dec 9, 2025 8:00 AM
